Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -15,040 | -10,248 | N/A | N/A |
| Depreciation Amortization | 150 | 25 | N/A | N/A |
| Accounts payable and accrued liabilities | 388 | 116 | N/A | N/A |
| Other Working Capital | 2,308 | -711 | N/A | N/A |
| Other Operating Activity | -6,430 | 1,276 | 0 | 0 |
| Operating Cash Flow | $-18,624 | $-9,542 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -560 | -266 | N/A | N/A |
| Investing Cash Flow | $-560 | $-266 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 26 | N/A | N/A | N/A |
| Other Financing Activity | 93,831 | 21,909 | 0 | 0 |
| Financing Cash Flow | $93,857 | $21,909 | $N/A | $N/A |
| Beginning Cash Position | 18,104 | 6,003 | N/A | N/A |
| End Cash Position | 92,777 | 18,104 | N/A | N/A |
| Net Cash Flow | $74,673 | $12,101 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -18,624 | -9,542 | N/A | N/A |
| Capital Expenditure | -560 | -266 | N/A | N/A |
| Free Cash Flow | -19,184 | -9,808 | 0 | 0 |